Gennao Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $15M

  • Investors
  • 5

Gennao General Information

Description

Developer of targeted nucleic acid therapeutics intended to cure muscle diseases. The company uses gene monoclonal antibody (GMAB) platform technology, which utilizes a novel, cell-penetrating antibody to non-covalently bind to and deliver therapeutic levels of a wide variety of nucleic acid payloads to select cells, enabling the medical community and patients to optimize outcomes related to rare monogenic skeletal muscle diseases.

Contact Information

Website
www.gennao.com
Formerly Known As
Delmab Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 311 Pennington Rocky Hill Road
  • Building Number 21, Hopewell
  • Pennington, NJ 08534
  • United States
+1 (212)
Primary Industry
Biotechnology
Corporate Office
  • 311 Pennington Rocky Hill Road
  • Building Number 21, Hopewell
  • Pennington, NJ 08534
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gennao Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 08-Dec-2022 $15M Completed Generating Revenue
1. Early Stage VC (Series A) 17-Dec-2021 Completed Startup
To view Gennao’s complete valuation and funding history, request access »

Gennao Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Gennao’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Gennao Patents

Gennao Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025213130-A1 Antibody drug conjugates Pending 04-Apr-2024
WO-2025049905-A1 Dnase co-expression in host cells Inactive 01-Sep-2023
WO-2024197302-A1 Compositions and methods for delivering antibody oligonucleotide conjugates for exon skipping Inactive 23-Mar-2023
WO-2024158824-A1 Antibody oligonucleotide conjugates Inactive 23-Jan-2023
WO-2024145398-A1 Antibody drug conjugates Inactive 27-Dec-2022 A61K47/6843
To view Gennao’s complete patent history, request access »

Gennao Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gennao Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
GordonMD Global Investments PE/Buyout Minority
CureDuchenne Ventures Corporate Venture Capital Minority
Logos Capital Hedge Fund Minority
OrbiMed Growth/Expansion Minority
Surveyor Capital Hedge Fund Minority
To view Gennao’s complete investors history, request access »

Gennao FAQs

  • When was Gennao founded?

    Gennao was founded in 2020.

  • Where is Gennao headquartered?

    Gennao is headquartered in Pennington, NJ.

  • What is the size of Gennao?

    Gennao has 11 total employees.

  • What industry is Gennao in?

    Gennao’s primary industry is Biotechnology.

  • Is Gennao a private or public company?

    Gennao is a Private company.

  • What is the current valuation of Gennao?

    The current valuation of Gennao is .

  • What is Gennao’s current revenue?

    The current revenue for Gennao is .

  • How much funding has Gennao raised over time?

    Gennao has raised $55M.

  • Who are Gennao’s investors?

    GordonMD Global Investments, CureDuchenne Ventures, Logos Capital, OrbiMed, and Surveyor Capital have invested in Gennao.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process